The role of CMV in glioblastoma and implications for immunotherapeutic strategies
Controversy surrounds the role of cytomegalovirus (CMV) in glioblastoma (GBM). However, several studies have shown that CMV nucleic acids and proteins are present within GBM tumor tissue. CMV has been implicated in GBM pathogenesis by affecting tumor stem cell factors, angiogenesis and immune pathwa...
Main Authors: | Maryam Rahman, Farhad Dastmalchi, Aida Karachi, Duane Mitchell |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-01-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2018.1514921 |
Similar Items
-
Current Immunotherapeutic Strategies for the Treatment of Glioblastoma
by: Mark Dapash, et al.
Published: (2021-09-01) -
Impact of pre‐therapy glioblastoma multiforme microenvironment on clinical response to autologous CMV‐specific T‐cell therapy
by: David G Walker, et al.
Published: (2019-01-01) -
Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies
by: Ana Rita Pombo Antunes, et al.
Published: (2020-02-01) -
Sarcosine promotes trafficking of dendritic cells and improves efficacy of anti-tumor dendritic cell vaccines via CXC chemokine family signaling
by: Farhad Dastmalchi, et al.
Published: (2019-11-01) -
Immunotherapeutic advancements for glioblastoma
by: Leonel eAmpie, et al.
Published: (2015-01-01)